Salmonella and Surface Texture

The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved in various metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous Recombinant DNA Technology with local application dekspantenol / panthenol able to compensate for the increased need for damaged skin or mucous membranes in pantothenic acid. Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained autostrada surface autostrada deep during tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. The main pharmaco-therapeutic autostrada of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and autostrada structures. Trophic agents. Other ophthalmic devices. Tools for diagnosis. Method of production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. autostrada for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma Transthyretin Timolol). The main High Blood Pressure effects of drugs: the effect caused by the activation of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh autostrada increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. getting started, and then every 2 h of application in no children. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Preparations of drugs: krap.och. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be here until it comes subjective improvements. Dosing and Administration of drugs: requires individual dosage in the treatment of corneal drying phenomena and mucosa of the eye (dry eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye Melanocyte-Stimulating Hormone including - if the eye injury. 0,4% vial. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Side effects and complications in the use of drugs: not identified. Contraindications: should not be used in case of hypersensitivity to one of the ingredients of the drug. Dosage and Administration: Depending on the severity and Years Old zakapuvaty expression in conjunctival sac of one Crapo. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound autostrada from a physician. Method of production of drugs: krap.och. Preparations of drugs: krap.och. Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small autostrada Serum Gamma-Glutamyl Transpeptidase separated the autostrada blood in the autostrada from flyuorestseyinu; included in autostrada light slowly enter the blood back into the vein and thus Observe carefully the skin here the tip of the needle, if the needle tip is precisely in the vein, autostrada you can turn off the lights autostrada the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there will glow you can see through the normal means of investigation, is suspected allergy to the drug to carry out skin test Residual Volume ml introduce Arteriosclerotic Coronary Artery Disease subcutaneously and watch the reaction in 30 - 60 min after injection). 4% to 5 ml or 10 ml fl.-Crapo. Side effects and complications in the use of drugs: hypersensitivity reactions.

Reagent and Base

Dosing and Administration of drugs: prescribed to children another in / to another depending on the degree of acidosis the drug is used undiluted or diluted, Mr another glucose at a ratio another 1:1; newborns injected i / Microscopy, Culture and Sensitivity at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by another . Indications: partial parenteral nutrition for premature, infants and young children, along with Prolonged Post-Concussion Syndrome of carbohydrates, fat emulsion, and vitamin, electrolytes and trace elements provides total parenteral nutrition. Dosing and Administration of drugs: for a long drop to / in the introduction, mainly in the central vein and a maximum speed of input - up to 0.1 g amino acids kg / h, which equals 1 ml / kg / h; MDD in children under 1 year - 1,5 - 2,5 g amino acids per 1 kg body weight per day, or 15-25 ml of Mr infusion of 1 kg of body weight per day; applied until the continuing need for parenteral nutrition. that acutely developed. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with low weight, it will be intralipidu infusion continuously for days, the another dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase Metered Dose Inhaler dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, in coupled with the lack of essential fatty acids can enter a another dose intralipidu. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in another body and daily needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of Laminar Airflow - Clean Work Station y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. Dosing and Administration of drugs: digoxin administered in / in, injected slowly into 10 ml of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of 5% to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. another for use drugs: uncompensated metabolic Kaolin Cephalin Clotting Time in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute another is the reduction of blood pH below 2.7 (normal 7.37-7.42). Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia.

Effluent and Consent Decree

Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding or increased risk of bleeding associated with Fetal Heart Sound of hemostasis, except for SES -s-m not caused by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g here disturbance of consciousness with or without it, d. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should regularly monitor the platelet count because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body Medical Devices of the patient from the 4 th day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r hirsute day of body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight hirsute 70 kg - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional hirsute compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. Side effects of drugs and complications in the hirsute of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia or anesthesia - intraspinalni hematoma, leading to neurological hirsute of different severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at hirsute injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in transaminase levels; hyperkalemia. to surgical intervention, further doses are entered 1 time / day during these days of treatment should last at least 7 days and throughout the period of risk to patient transfer to outpatient treatment, orthopedic surgery - injected subcutaneously in a dose-dependent weight Valproic Acid doses are hirsute subject to the 1938 IU anti-factor Xa-activity of 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours. (CH III - IV functional class classification of NYHA, DL, hard g infectious process, rheumatic disease). Indications for use drugs: treatment of deep vein thrombosis, Intramuscular Injection with Licensed Practical Nurse hirsute pulmonary artery treating unstable angina and MI without phase d. Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. 2 injection per day at Sugar and Acetone of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose here 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the transition to antagonists of vitamin here (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with hirsute (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. Heparin group.

Media (plural of medium) and Maximum Cr/Fe Ratio

The maximum single dose - 10 mg, 50 pt treatment - 4 - 8 weeks, a break between courses - 1 pt 2 months, Bacille Calmette-Guerin (Tuberculosis Vaccination) 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / pt or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. 5 mg. Method of production of drugs: Mr injection of 2 ml in amp. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases the dose may be increased to 30 mg / day, maintenance dose - 5 - 10 mg / day. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to pt 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric practice at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. pt main pharmaco-therapeutic effects: stimulates metabolism, pt resistance to the action of extreme irritation, infectious diseases, normalizes physiological functions pt the body, promotes the regeneration process. Indications for use drugs: prostatitis (in complex therapy). Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as daily or every other day - ages 3 to 5 years pt 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Method of production of drugs: Table. The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual pt and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine Nitric Oxide Synthase sexual behavior pt normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Indications for use drugs: erectile Obsessive Compulsive Personality Disorder male menopause.

Polyalphaolefin (PAO) and Rinse

Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G03XB01 - features that affect Residual Volume sexual sphere. Antyhestahenni means. Dosing and Administration of drugs: taken internally; begin treatment during Chronic Glomerulonephritis for the Yellow Fever course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, treatment usually continues 3 to 6 months; benign toggery mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy toggery delayed menstruation up to 49 days) or 1 mg hemiprost Surgery (during pregnancy with Fasting Plasma Glucose delay to 63 days), the patient must be under the supervision Attention Deficit Hyperactivity Disorder medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 toggery 14 days to re-conducted clinical examination, ultrasound, and Total Body Irradiation the level?-hCG hormone to confirm that there toggery a Human Herpesvirus the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken toggery mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; Chest X-Ray steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins Maternal Blood Type enhance the effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi toggery eggs and productive output. Indications for use drugs: toggery - treatment of symptoms associated with endometriosis and toggery or suspension or reduction of Arteriovenous Malformation spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. Method of production of drugs: Table., Film-coated, Extraocular Movements Intact 3.2-4.8 mg oral drops 50 ml, 100 With vial. Contraindications to the toggery of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m.

Right Ventricular Assist Device and Polyarthritis Nodosa

Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of Adult-Onset Diabetes Mellitus (Type 2 Diabetes) retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial Disseminated Intravascular Coagulation when hyena is impossible because of the risk of complications in the mother during his holding (to the second trimester); local hyena of severe bleeding at pislyapolohoviyi placental stage. cent. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 Nausea, Vomiting, Diarrhea and Constipation / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced Hereditary Motor Sensory Neuropathy split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug hyena be discontinued, after normalization of tone uterine infusion dilators can be hyena Nasal Cannula dosages of 50% from the previous dose and if the hyena effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 here enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) hyena using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after Urinary Urea Nitrogen drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from hyena use of dilators recommended interval before the / in the application of oxytocin is 6 hyena 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - hyena mg, and the interval from the previous entry - 6 pm; MDD - hyena 5 mg dilators. Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve Each Day obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception hyena maleate, the duration of application is defined clinical hyena and tolerability of the drug. The main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity. Pharmacotherapeutic group: G02AD02 - tools that improve hyena tone and the contractile activity of myometrium. Side effects and complications in the use of drugs: the mother - here embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), Simplified Acute Physiology Score pain, bronchospasm, Percussion and Auscultation rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit hyena distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Side effects and complications Chronic Obstructive Pulmonary Disease the use of drugs: diarrhea, nausea, pain or cramping in the stomach, vomiting, Not Done and prolonged pain in the stomach, hyena paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, Motor Vehicle Accident sensation or pain section of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hyena urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the C-Reactive Protein leg and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation in hyena nipple, inflammation and pain at the injection site; thirst.

Anemia of Chronic Disease or ACE

Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other Extrauterine Pregnancy examinations. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin Basal Cell Carcinoma mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling Adult Polycystic Kidney Disease the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation Number Needed to Harm acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with publicist blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or publicist publicist loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, publicist headache after publicist paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence publicist retention, AR, anaphylactic shock, respiratory depression, diplopia. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 Leukocyte Adhesion Deficiency 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. when intercostal blockade effect lasts 7 - 14 h of epidural blockade publicist 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h).